Showing results (1811-1820 of 3,978) with videos related to
Sort By:
Pageof 398
European Journal of Heart Failure|June 13, 2020
18 F-FDG PET/CT brain glucose metabolism as a marker of different types of depression comorbidity in chronic heart failure patients with impaired systolic functionVassiliki Lyra, John Parissis, Maria Kallergi, et al.European Journal of Heart Failure|May 21, 2020
Guideline-directed medical therapy for heart failure does not exist: a non-judgmental framework for describing the level of adherence to evidence-based drug treatments for patients with a reduced ejection fractionMilton Packer, Marco MetraEuropean Journal of Heart Failure|May 23, 2020
Impact of recent heart failure hospitalization on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the PARTNER 2 trial and registriesShmuel Chen, Bjorn Redfors, Aaron Crowley, et al.European Journal of Heart Failure|September 9, 2021
Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC)Wouter C Meijers, Antoni Bayes-Genis, Alexandre Mebazaa, et al.European Journal of Heart Failure|January 31, 2023
Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluationPhil McEwan, Cale Harrison, Rhona Binnie, et al.European Journal of Heart Failure|March 15, 2023
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosisAlberto Aimo, Daniela Tomasoni, Aldostefano Porcari, et al.European Journal of Heart Failure|November 20, 2022
Sequencing and titrating approach of therapy in heart failure with reduced ejection fraction following the 2021 European Society of Cardiology guidelines: an international cardiology surveyCharles Fauvel, Guillaume Bonnet, Wilfried Mullens, et al.European Journal of Heart Failure|November 20, 2022
Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathyMatthew T Wheeler, Daniel Jacoby, Perry M Elliott, et al.European Journal of Heart Failure|November 20, 2022
β3 adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trialAna García-Álvarez, Isabel Blanco, Inés García-Lunar, et al.European Journal of Heart Failure|November 27, 2025
Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus documentLuca Monzo, Gianluigi Savarese, Wilfried Mullens, et al.Pageof 398